Folgen
Ramón Fernández-Bobadilla
Ramón Fernández-Bobadilla
Bestätigte E-Mail-Adresse bei santpau.cat
Titel
Zitiert von
Zitiert von
Jahr
Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase
J Pagonabarraga, S Martinez‐Horta, R Fernández de Bobadilla, J Pérez, ...
Movement Disorders 31 (1), 45-52, 2016
2282016
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease
S Martinez-Horta, J Perez-Perez, E Van Duijn, R Fernandez-Bobadilla, ...
Parkinsonism & related disorders 25, 58-64, 2016
1592016
Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing
S Martínez-Horta, J Riba, RF de Bobadilla, J Pagonabarraga, ...
Journal of Neuroscience 34 (17), 5918-5926, 2014
152*2014
Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale
J Kulisevsky, RF de Bobadilla, J Pagonabarraga, S Martínez-Horta, ...
Parkinsonism & related disorders 19 (9), 812-817, 2013
1012013
Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment
R Fernandez de Bobadilla, J Pagonabarraga, S Martínez‐Horta, ...
Movement Disorders 28 (10), 1376-1383, 2013
942013
Validación de la versión espańola del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia
JA Matias-Guiu, RF de Bobadilla, G Escudero, J Pérez-Pérez, A Cortés, ...
Neurologia 30 (9), 545-551, 2015
862015
Clinical manifestations of intermediate allele carriers in Huntington disease
E Cubo, MA Ramos-Arroyo, S Martinez-Horta, A Martínez-Descalls, ...
Neurology 87 (6), 571-578, 2016
552016
Non-demented Parkinson’s disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes
S Martinez-Horta, F Sampedro, J Pagonabarraga, R Fernandez-Bobadilla, ...
Brain imaging and behavior 11, 1334-1342, 2017
522017
Normative data for the Spanish version of the Addenbrooke's Cognitive Examination III
JA Matías-Guiu, R Fernández-Bobadilla, A Fernández-Oliveira, ...
Dementia and geriatric cognitive disorders 41 (5-6), 243-250, 2016
442016
Neurophysiological evidence of compensatory brain mechanisms in early-stage multiple sclerosis
M López-Góngora, A Escartín, S Martinez-Horta, R Fernandez-Bobadilla, ...
PloS one 10 (8), e0136786, 2015
412015
Parkinson's disease: impulsivity does not cause impulse control disorders but boosts their severity
J Marín-Lahoz, J Pagonabarraga, S Martinez-Horta, ...
Frontiers in psychiatry 9, 465, 2018
342018
Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers
P Gassó, K Papagianni, S Mas, RF De Bobadilla, JA Arnaiz, M Bernardo, ...
Pharmacogenomics 14 (13), 1551-1563, 2013
332013
Head-to-head comparison of the neuropsychiatric effect of dopamine agonists in Parkinson’s disease: a prospective, cross-sectional study in non-demented patients
J Pérez-Pérez, J Pagonabarraga, S Martínez-Horta, ...
Drugs & Aging 32, 401-407, 2015
302015
Validation of the Spanish-language version of Mini-Addenbrooke's Cognitive Examination as a dementia screening tool
JA Matias-Guiu, R Fernandez-Bobadilla
Neurologia (Barcelona, Spain) 31 (9), 646-648, 2016
272016
Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double‐blind, crossover, placebo‐controlled trial
S Mas, P Gassó, R Fernandez de Bobadilla, JA Arnaiz, M Bernardo, ...
Human Psychopharmacology: Clinical and Experimental 28 (6), 586-593, 2013
272013
Clinical and genetic characteristics of late-onset Huntington's disease
M Oosterloo, EK Bijlsma, SM Van Kuijk, F Minkels, CEM de Die-Smulders
Parkinsonism & related disorders 61, 101-105, 2019
262019
Spanish REGISTRY investigators of the European Huntington’s Disease Network, Kulisevsky J. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington’s …
S Martinez-Horta, J Perez-Perez, E van Duijn, R Fernandez-Bobadilla, ...
Parkinsonism Relat Disord 25, 58-64, 2016
252016
Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial
P Gasso, S Mas, K Papagianni, E Ferrando, RF De Bobadilla, JA Arnaiz, ...
Pharmacogenomics 15 (1), 17-28, 2014
192014
Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls
B Gómez-Ansón, E Roman, R Fernández de Bobadilla, P Pires-Encuentra, ...
PLoS One 10 (3), e0118930, 2015
172015
Parkinson's Disease—Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment
E Ruzafa-Valiente, R Fernández-Bobadilla, C García-Sánchez, ...
Journal of the neurological sciences 361, 66-71, 2016
152016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20